MaxCyte
MXCT
#9472
Rank
$0.13 B
Marketcap
$1.26
Share price
1.21%
Change (1 day)
-4.92%
Change (1 year)

Revenue for MaxCyte (MXCT)

Revenue in 2026 (TTM): $32.28 Million USD

According to MaxCyte's latest financial reports the company's current revenue (TTM ) is $32.28 Million USD. In 2025 the company made a revenue of $33.02 Million USD a decrease over the revenue in the year 2024 that were of $38.62 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for MaxCyte from 2021 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) $32.28 M-2.24%
2025 $33.02 M-14.5%
2024 $38.62 M-6.44%
2023 $41.28 M-6.72%
2022 $44.26 M30.59%
2021 $33.89 M